CircRNA RNA hsa_circ_0008234 Promotes Colon Cancer Progression by Regulating the miR-338-3p/ETS1 Axis and PI3K/AKT/mTOR Signaling
Open Access
Abstract
Circular RNAs (circRNAs) have been shown to play a crucial role in cancer occurrence and progression. This present work investigated the link between hsa_circ_0008234 and colon cancer. Data retrieved from GSE172229 was used to compare the circRNA profiles of colon cancer and surrounding non-tumorous tissues. The amount of RNA and protein in the molecules was determined using quantitative real-time PCR (qRT-PCR) and Western blot analysis, respectively. The cell proliferation ability was assessed using CCK8, EdU, colon formation, and nude mice tumorigenesis tests. Cell invasion and migration abilities were evaluated using transwell wound healing and mice lung metastasis model. Hsa_circ_0008234 piqued our interest because bioinformatics and qRT-PCR analyses revealed that it is upregulated in colon cancer tissue. Cell phenotypic studies suggest that hsa_circ_0008234 may significantly increase colon cancer cell aggressiveness. Mice experiments revealed that inhibiting hsa_circ_0008234 significantly reduced tumor growth and metastasis. Moreover, the fluorescence in situ hybridization experiment demonstrated that hsa_circ_0008234 is primarily found in the cytoplasm, implying that it potentially functions via a competitive endogenous RNA pathway. These findings indicated that hsa_circ_0008234 may act as a “molecular sponge” for miR-338-3p, increasing the expression of miR-338-target 3p’s ETS1. In addition, the traditional oncogenic pathway PI3K/AKT/mTOR signaling was found to be the potential downstream pathway of the hsa_circ_0008234/miR-338-3p/ETS1 axis. In conclusion, hsa_circ_0008234 increases colon cancer proliferation, infiltration, and migration via the miR-338-3p/ETS1/PI3K/AKT axis; therefore, it could serve as a target and a focus for colon cancer therapy.Keywords
Funding Information
- Young Medical Talents Training Program of the Pudong Health Committee of Shanghai (PWRq2020-67, PKJ2021–Y38, Tszb2023-01, Zdzk2020-10, Zdxk2020-01)
- Science and Technology Development Fund of Shanghai Pudong New Area (PWRq2020-67, PKJ2021–Y38, Tszb2023-01, Zdzk2020-10, Zdxk2020-01)
- Discipline Construction Promoting Project of Shanghai Pudong Hospital (PWRq2020-67, PKJ2021–Y38, Tszb2023-01, Zdzk2020-10, Zdxk2020-01)
This publication has 44 references indexed in Scilit:
- MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancerBiomedicine & Pharmacotherapy, 2017
- CircRNA: a novel type of biomarker for cancerBreast Cancer, 2017
- From tumour heterogeneity to advances in precision treatment of colorectal cancerNature Reviews Clinical Oncology, 2016
- The role of the transcription factor Ets1 in carcinomaSeminars in Cancer Biology, 2015
- ceRNA in cancer: possible functions and clinical implicationsJournal of Medical Genetics, 2015
- Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual PatientsJournal of Clinical Oncology, 2015
- Biogenesis of Circular RNAsCell, 2014
- Colon cancerCritical Reviews in Oncology/Hematology, 2010
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Modifiable risk factors for colon cancerGastroenterology Clinics of North America, 2002